CBER - Office of Vaccines Research and Review - Organization - Text version

The following header reflects the organizational hierarchy.

FOOD AND DRUG ADMINISTRATION

OFFICE OF MEDICAL PRODUCTS AND TOBACCO

CENTER FOR BIOLOGICS EVALUATION AND RESEARCH

OFFICE OF VACCINES RESEARCH AND REVIEW

The following is the communication box containing information to assist anyone who may want to communicate with the depicted organization via telephone, facsimile or mail.

Main tel:           301-796-2630

Fax:                 301-402-1290

Address:          WOC2, 3^rd Floor

1401 Rockville Pike

Rockville, MD  20852

The following is the Food and Drug Administration, Office of Medical Products and Tobacco, Center for Biologics Evaluation and Research, Office of Vaccines Research and Review organization structure depicting all the organizational structures reporting to the Office Director.  These organizational structures are organized in sequential order by their assigned Standard Administrative code (Alphanumeric sequence of characters beginning with the letter D).

Each organizational component will be depicted in the following standard format:

Title of organization.

Position title of the manager.

Military rank if any, first name, middle initial if any, last name, post graduate degrees if any, and if the individual is designated as acting.

Standard Administrative code.

DIRECTOR

Marion F. Gruber, Ph.D.

Reports directly to the Office Director

DEPUTY DIRECTOR

Philip R. Krause, M.D. (Acting)

ASSOCIATE DIRECTOR FOR REGULATORY POLICY

Theresa M. Finn, Ph.D.

ASSOCIATE DIRECTOR FOR RESEARCH

Konstantin Chumakov, Ph.D.

ASSOCIATE DIRECTOR FOR SCIENTIFIC AFFAIRS

Erik A. Henchal, Ph.D.

ASSOCIATE DIRECTOR FOR MEDICAL POLICY AND VACCINE SAFETY

Karen Farizo, M.D. (Acting)

(DKKBF)

Approved by the FDA Reorganization Coordinator and Principal Delegation Control Officer